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Exploring the Human Intestinal Microbiome in Health and Disease 
Abstract 
In this thesis, molecular tools were used to study bacteria inhabiting the 
gastrointestinal tract of humans. One aim was to determine whether certain lifestyle 
factors, such as an anthroposophic lifestyle, or living on a farm, had an impact on 
the bacterial composition in fecal samples collected from 90 children. The bacterial 
composition was determined by terminal restriction fragment length polymorphism 
(T-RFLP). Each child had a unique bacterial community, but anthroposophic 
children had a higher bacterial diversity than farm children. A second aim was to 
study the bacterial communities in fecal samples and biopsies collected from patients 
with Crohn’s disease (CD), compared to healthy individuals. Several molecular 
approaches were used to characterize the microbiota in identical twins, including 
healthy twins pairs and twins that were discordant (one has CD and one is healthy) 
or concordant (both have CD). The bacterial profiles of healthy twins were highly 
similar whereas in twins discordant for CD they were very different. An imbalance 
in the microbiota was observed in a subset of individuals with CD and was 
correlated with the ileal disease phenotype (ICD). A reduced diversity of Firmicutes, 
and in particular, a depletion of Faecalibacterium prausnitzii was correlated with ICD. 
By contrast there was an increased prevalence and abundance of E. coli in ICD 
individuals. These findings suggest that specific members of the gut microbiota play 
a functional role in ICD and this could have clinical significance. A third aim was to 
characterize the microbiota in stomach biopsies from individuals with stomach 
cancer compared to healthy individuals. The gastric cancer microbiota had a high 
bacterial diversity and a similar composition to that in dyspeptic controls. In both 
cases, the bacterial composition was dominated by streptococci and other Firmicutes 
and a low abundance of Helicobacter pylori, contradicting earlier reports of H. pylori 
dominance in the stomach. In conclusion, the bacterial community in the human 
gastrointestinal tract is more complex than originally thought and disturbances in 
this community are indicative of some disease states. 
Keywords: Microbiota, terminal-restriction fragment length polymorphism (T-
RFLP), gastrointestinal tract, identical twins, inflammatory bowel disease (IBD), 
Crohn’s disease, gastric cancer, Faecalibacterium prausnitzii, lifestyle, diversity. 
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1 Introduction 
The world of microbes, although invisible to the human eye, encompasses 
all types of ecological niches. For a microbiologist it is particularly intriguing 
to know that one of the most complex microbial ecosystems on earth lies 
enclosed within our bodies. The number of microbes residing in our gut 
exceeds the number of our own body cells by a factor of ten and thousands 
of different microbial species reside in our intestinal tract (Bäckhed et al., 
2005). Together, all of these microorganisms (collectively called the 
microbiota) harbor a repertoire of protein encoding genes that by far 
exceeds the gene pool found in our human genome. For more than a 
century researchers have been trying to understand the role of the intestinal 
microbiota for our well-being. In the past few decades increasing evidence 
has revealed that the intestinal microbiota harbors a tremendous potential to 
interact and interfere with the host, in both positive and negative ways. The 
relationship between the host and the gut microbiota is symbiotic and 
mutualistic interactions include microbial breakdown of otherwise non-
digestible compounds that reach the large bowel. In addition, the products 
from microbial fermentation processes contribute to up to ten per cent of 
the host energy uptake (Macfarlane & Macfarlane, 2007), and are thought to 
be important to maintain gut health (Pryde et al., 2002). Furthermore, the 
microbiota produces some essential vitamins and can have a functional 
barrier effect, protecting from pathogen invasion by colonizing mucosal 
surfaces (Stecher & Hardt, 2008). Studies of germ free animals have 
provided insights into the importance of the gut microbiota for maturation 
of the host. For example, it has been demonstrated that the microbiota plays 
an essential role in shaping our immune system (Hooper et al., 2003; 
Mazmanian et al., 2005), and intriguingly, it may exert behavioral effects on 
humans (Parracho et al., 2005). Potential negative impacts in addition to 
pathogenesis include conversion of drugs or dietary compounds to 
carcinogenic compounds (Hope et al., 2005). Importantly, the microbiota   10
has been implicated to play a critica l  r o l e  i n  s e v e r a l  d i s e a s e s  o f  t h e  
gastrointestinal tract. Inflammatory bowel diseases, intestinal cancers, 
allergies and obesity are examples of such diseases; yet, the microbial role in 
the etiology of these diseases largely remains an enigma. 
 
Despite a century of research, the work to elucidate the role of the microbial 
gut inhabitants in health and disease is still in its infancy. However, recent 
advances in new technologies and a large medical interest in this field of 
science will hopefully provide more insights to understanding the link 
between microbial ecology and human diseases. Recently, there has been 
research interest in sequencing the next human genome; i.e. the human 
microbiome. This is a global large scale effort with the aim to define a core 
microbiome for mankind, and to understand which host and environmental 
factors contribute to the dynamics of the human microbiome (Turnbaugh et 
al., 2007). 
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2 The healthy gut microbiota 
Starting in the mouth, the human digestive system runs through the body 
and approximately seven meters later it ends with the anus. This system is 
the home of an enormous number of organisms including bacteria, yeast, 
fungi, protozoa and viruses. Due to great physiological differences along the 
digestive tract, the presence and function of microbial communities varies 
largely at different sites of our body. Many of the bacteria are normal 
commensal inhabitants and colonizers of some part of the gut, whereas 
others are just transient, and follow the body fluids through the system. 
However, the relative abundances and contributions of indigenous versus 
transient members of the microbiota is currently not known. Regardless of 
intestinal site and whether they are residents or transients, many of these 
microbes play an important role in the gastrointestinal tract.  
2.1 Function of the microbiota 
The commensal microbiota have important and specific functions for the 
host. These can be divided into three main groups; trophic, protective and 
metabolic (Guarner & Malagelada, 2003). Trophic functions include control 
of proliferation, differentiation of epithelial cells and immune system 
maturation. The protective role of the microbiota is by occupying intestinal 
surfaces and creating a stability of the system and a milieu that prevents 
invasion from exogenous microbes, for example, by production of 
antimicrobial compounds. Metabolic functions include breakdown of non-
digestible compounds by anaerobic fermentation, such as resistant starch and 
plant polysaccharides, which generates short chain fatty acids (SCFA) that 
serve as growth signals and fuel for the intestinal epithelium as well as for 
other microbes.  In particular, butyrate has gained large attention for its 
health promoting properties (D'Argenio & Mazzacca, 1999; Pryde et al., 
2002; Wong et al., 2006). Another example of metabolic function provided   12
by the microbiota is the production of some vitamins, such as, vitamin K 
and B12, synthesis of amino acids and digestion of proteins. In exchange, the 
host provides a stable habitat with a constant flow of food and nutrients.  
2.2 Establishment of the microbiota 
We are born sterile but immediately after birth a microbial community starts 
to establish (O'Hara & Shanahan, 2006).  The first inocula come from the 
mother, by the birth canal, and/or a fecal-oral route, and from the 
surrounding area. For example, the same serotype of Escherichia coli was 
found in the mouths of newborn babies as in feces from their mothers 
(Brook et al., 1979). The microbial composition and colonization pattern 
varies widely from baby to baby (Palmer et al., 2007). During the first 
months of life the community is highly variable and dominated with a 
facultative anaerobic microbiota. When space and nutrients are not limiting, 
bacteria with high division rates are more prevalent. However, over time, 
when the system becomes more densely populated and nutrient supply is 
limited, a more specialized microbiota takes over (Hooper et al., 1999). The 
microbiota of the children becomes progressively more complex and at the 
age of two the microbial community is stabilized and an adult-like flora 
established with a large predominance of anaerobic microbes (Favier et al., 
2002). Without outer environmental stresses the dominant microbiota is 
considered to be remarkably stable over time (Ley et al., 2006b; Vanhoutte 
et al., 2004; Zoetendal et al., 1998). However, by studying subgroups of the 
microbiota, temporal variation was observed in the lactobacilli population 
and  Enterococcus population, whereas Bacteroides spp. and bifidobacteria 
remained relatively stable (Jernberg et al., 2007; Vanhoutte et al., 2004).  
2.3 The microbiota of the upper digestive tract 
A complex microbiota of more than 700 different species with 
representatives from six phyla (Figure 1) has been found in the oral cavity of 
humans (Aas et al., 2005). The mouth is comprised of many different types 
of surfaces, all with a distinct microbial profile. However, some genera are 
common to all sites of the mouth, and these are Gemella,  Granulicatella, 
Streptococcus, and Veillonella (Aas et al., 2005). Oral microbial communities 
are commonly found in biofilms and it is probable that a metabolic inter-
dependency is important for shaping these communities (Jenkinson & 
Lamont, 2005). Bacteria are introduced in the esophagus either by 
swallowing or by reflux from a colonized stomach (Pei et al., 2004). 
Previously, it was generally thought that the esophagus was sterile or 
contained transients from the oral cavity due to the short retention time and   13
flushing of foods and fluids ingested by the host. However, Pei et al. (2004) 
showed that a diverse microbiota colonizes the mucosal surfaces of the 
esophagus. They found 95 phylotypes with representatives from six different 
phyla (Figure 1). Many of these were novel but culturable. In addition, this 
microbiota shares many members that usually are found in the oral cavity.   
 
 
Figure 1. Distributions of bacterial phyla at different anatomical sites of the body. Each area 
corresponds to the abundance of phylotypes belonging to different phyla. Data derived from 
Dethlefsen et al. (2007), with permission from the publisher. Between 3 and 11 individuals 
were studied per habitat.  
The stomach is the first line in the body’s defense that microbes encounter 
as they enter the gastrointestinal tract. The acidic environment is thought to 
be an effective barrier, killing off most of the microbes in their passage 
through the stomach into the small bowel. In addition, a short transit time   14
contributes to the relatively low number of bacteria that are found in the 
stomach (Guarner, 2006). Previously the healthy stomach was considered to 
be otherwise sterile and not colonized by any microbes (Hentges, 1983). 
However, the gastric mucosa was hiding a secret that was discovered more 
than two decades ago (Marshall & Warren, 1984). Helicobacter pylori is 
nowadays a well studied colonizer of the gastric mucosa. Expression of the 
urease enzyme allows its survival in the acidic environment during its active 
passage into the mucus layer of the stomach lining where the pH is almost 
neutral. Additional bacteria have been found in the stomach, such as 
streptococci and lactobacilli, enterobacteria and other members of the oral 
cavity (Savage, 1977). There is no evidence that other bacteria than H. pylori 
can colonize the healthy stomach. However, streptococci are frequently 
isolated and some species may have the ability to survive the acidic 
environment. For example, Streptococcus salivarius exerts urease activity 
(Sissons & Hancock, 1993) and one can hypothesize that this can enable it to 
persist in the stomach. Recent advances in molecular biology have shown a 
more diversified gastric microbiota than previously thought. For example, 
Bik et al. (2006) found 128 phylotypes from gastric mucosa, with 
representatives from six bacterial divisions (Figure 1). This set of organisms 
was distinguished from what has been found in the mouth and esophagus, 
suggesting that the stomach is home for a distinct microbial ecosystem (Bik 
et al., 2006).  
2.4 Microbiota of the small bowel 
The small bowel, comprised of duodenum, jejunum and ileum (Figure 2), is 
the main site for digestion of foods and absorption of nutrients in the body. 
Bile, pancreatic secretions and flushing mechanisms restrict the bacterial 
density in the proximal parts of the small bowel (O'Hara & Shanahan, 2006) 
whereas a lower transit rate increases bacterial density dramatically in the 
distal regions (Booijink et al., 2007). Due to technical difficulties in 
sampling, the residential microbiota is not well characterized. According to 
current knowledge, the duodenal and jejunal microbiota is predominated by 
facultative anaerobes, mainly acid tolerant lactobacilli and streptococci 
(Hayashi et al., 2005; Wang et al., 2005). The obligate anaerobic Firmicutes 
that dominate the microbiota of the large bowel are not commonly found in 
the upper parts of the small bowel (Hayashi et al., 2005). However, the distal 
part of the ileum hosts a more diverse microbiota and it resembles that of the 
colonic microbiota.      15
 
Figure 2. Overview of the human gastrointestinal tract. Within the gastrointestinal tract, 
mucus, a complex polymeric gel, covers the epithelial cell surface so it is not in contact with 
the luminal flow. This illustration showing the structure within the bowel is simplified and 
does not reflect true proportions.  
2.5 Microbiota of the large bowel 
The large bowel, comprised of ascending, transverse, descending colon and 
rectum (Figure 2), is the primary site for microbial persistence in the human 
body. The number of bacteria is estimated to be 10
11-10
12 bacteria/gram 
colonic content (O'Hara & Shanahan, 2006). The anaerobic condition 
promotes fermentation and obligate anaerobic bacteria outnumber 
facultative anaerobic bacteria. Even if the bacterial diversity is very high, the 
large bowel contains few phyla and is totally dominated by two; i.e. 
Bacteroidetes and Firmicutes comprise over 90 % of the bacteria found in the 
large bowel (Figure 1; Ley et al., 2006b). Despite great physiological 
differences between the proximal and distal parts of the colon, bacteria are 
uniformly distributed along the length of the large bowel. There are, 
however, some differences in bacterial types found in biopsies compared 
with those found in feces (Eckburg et al., 2005; Lepage et al., 2005; Nielsen 
et al., 2003; Zoetendal et al., 2002).  
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The number of bacteria found in the luminal region of the intestinal lining 
outnumbers the bacteria found within the mucus layer (Figure 2). 
Approximately 10
5 to 10
6 bacteria have been detected per biopsy from the 
colonic wall (Zoetendal et al., 2002). In contrast, several studies have failed 
to detect bacteria on the epithelial surface from healthy individuals (Kleessen 
et al., 2002; Swidsinski et al., 2007; van der Waaij et al., 2005). It has been 
challenging to get correct estimates of the number and types of bacteria in 
the bowel using traditional cultivation-based approaches because the 
majority of the bacteria found in the large bowel have not yet been cultured. 
This challenge was exemplified in a large survey of the gut microbiota using 
molecular approaches; i.e. cloning and sequencing (Eckburg et al., 2005), 
with the finding that 80% of the species represented by the clones had never 
previously been cultured.  
2.6 Factors influencing the microbial structure 
The dominant microbial communities of the large bowel have shown a 
remarkable stability over time during adulthood, (Ley et al., 2006b; 
Vanhoutte et al., 2004; Zoetendal et al., 1998) yet the microbial community 
profiles are unique for each individual (Eckburg et al., 2005; Ley et al., 
2006b). However, there are numerous external factors that have potential to 
influence the microbial composition in the gut. Which factors and to what 
extent these can contribute are poorly understood. Therefore, it is important 
to set up well-designed studies to reduce the number of confounding factors 
as far as possible to better elucidate the role of specific factors on the gut 
microbial composition.  
2.6.1 Host genetics   
The structure of the intestinal microbiota has also been shown to be 
dependent on host genetics. Zoetendal et al. (2001) studied the fecal 
microbiota of individuals with different degrees of genetic relatedness, 
ranging from monozygotic twins to unrelated individuals. Monozygotic 
twins that lived apart for years showed high similarities in their microbial 
profiles whereas marital partners that lived in the same environment and 
with comparable feeding habits, did not. Van de Merwe et al. (1983), 
compared the culturable fraction of the fecal microbiota between mono and 
dizygotic twins and found higher similarities within monozygotic pairs. This 
difference was confirmed in young children, living in the same household 
(Stewart et al., 2005). Animal studies have also supported the importance of 
genetic influence on the microbial composition. Ley et al. (2005), showed in 
a mouse model that three generations of offspring shared some similarities in 
their cecal microbiota, and these similarities were not seen when different   17
families of mice were compared. Taken together, these findings strongly 
argue that genetic factors provide a strong force in shaping the gut 
microbiota. However, colonization history and inoculum at birth from 
mother to child cannot be excluded to also be of importance for the similar 
microbial communities found among twins. 
2.6.2 Birth delivery mode 
The birth delivery mode has also been shown to influence the composition 
of the microbiota, with slower diversification and lack of anaerobic species, 
such as clostridia, in infants delivered by cesarean section (Grönlund et al., 
1999). In another study, a lower prevalence of clostridial species in the 
microbiota of a cesarean section delivered child, was prolonged over a 
period of several years (Salminen et al., 2004). 
2.6.3 Geographical impacts  
There have also been reports that geographical region can have an impact on 
the gut microbial composition. For example, the gut microbiota has been 
shown to differ between westernized developed countries, Asian and 
developing countries. H. pylori has been found to be more prevalent in 
developing countries than in developed countries (Genta et al., 1995). In 
another study, the microbiota of Estonian infants was shown to differ from 
the microbiota of Swedish infants (Björksten et al., 1999).  However, it has 
not yet been properly investigated whether these region- based discordances 
are based on the local environment, climate, genetic, dietary, or other 
factors connected to different lifestyles. In one study, local variations in the 
microbiota of the western European population were correlated to age, i.e. 
adult compared with elderly (Mueller et al., 2006). For example, country 
and age interactions were observed for German and Italians with inverse 
interactions for the predominating Clostridium coccoides and Bacteroides-
Prevotella groups. Contrary to this observation, no significant differences in 
the microbial composition were observed of individuals from five European 
countries (Lay et al., 2005).  
2.6.4 Influence of ageing 
Due to an altered physiology in elderly, with a decreased intestinal motility, 
reduced secretion of gastric acid, and a change of dietary habits and lifestyle, 
the microbiota in elderly persons differs from younger adults, although with 
great individual variations. In elderly persons, it is common to have a 
reduction in numbers and diversity of Bacteroides and bifidobacteria, and a 
reduced production of SCFA and amylolytic activity. In addition, increased 
numbers of facultative anaerobes, fusobacteria, clostridia and eubacteria but 
decreased numbers of bifidobacteria have been reported in elderly people   18
(Woodmansey, 2007). Although there is large disagreement in the findings 
between studies, probably due to individual differences and use of different 
methods, the abundance and diversity of bifidobacteria is consistently 
reported to be decreased in elderly individuals (Mueller et al., 2006; 
Woodmansey, 2007).  
2.6.5 Influence of diet 
Diet is often of interest for research studies due to its potential for 
modulation of the intestinal microbiota of the host, either in a beneficial or 
detrimental way. Dietary habits are considered to impact the microbial 
composition in the gut, in particular during the first years of life. For 
example, the fecal microbiota differs between breast-fed and formula fed 
infants, with more lactic acid bacteria and bifidobacteria in the breast-fed 
infants (Balmer & Wharton, 1991; Harmsen et al., 2000). However broadly 
defined diets such as a “Western diet”, comprised of a high intake of fat and 
animal proteins but low fiber, and a “Japanese diet”, with less fat and more 
vegetables, have only revealed moderate differences in the gut microbiota 
involving a few bacterial genera (Finegold & Sutter, 1978). Similar 
observations were made by Aries et al. (1971), that only observed small 
differences in the bacterial composition when persons on a normal mixed 
diet were compared with strict vegetarians (Aries et al., 1971). In another 
study a shift in the bacterial SCFA profile was observed between individuals 
that had an uncooked extreme vegan diet for one month compared to 
individuals that had a westernized diet. However, this shift was not reflected 
in the bacterial community composition (Peltonen et al., 1992). Diet is 
likely to have larger effects on microbial communities in the small intestinal 
due to a more diversified substrate supply in that location compared to the 
colon. The dietary effects of the small bowel microbiota could explain the 
large temporal variations of the microbiota in small intestinal digesta 
(Booijink et al., 2007) but not in feces (Zoetendal et al., 1998). However, 
recently it was shown that diet could promote a division wide change of the 
microbiota. Obese people that were randomly assigned a fat restricted or 
carbohydrate restricted low calorie diet over a year, showed a pronounced 
increase in the abundance of Bacteroidetes with a corresponding decrease of 
Firmicutes (Ley et al., 2006b).  
2.6.6 Impact of antibiotics 
It is well known that the microbiota can be strongly affected by antibiotic 
treatment. Recently, it was shown that the gut microbial composition could 
be disrupted for a long period of time, up to 2 years in some cases (Jernberg 
et al., 2007; Löfmark et al., 2006), depending on the antibiotics used. 
Jernberg et al. (2007) showed that the Bacteroides community never re-  19
established to its original composition within two years after a 7-day 
clindamycin treatment. Even if the original pre-antibiotic microbial 
composition is disrupted, it is generally assumed that the function of the 
entire microbial community is re-established (Norin, 1997). Still, more 
studies are necessary to determine what effect a population shift of the 
microbiota will have over a long period of time on host physiology.   
2.6.7 Pre- and probiotics 
The beneficial effects of fermented foods on human health were known 
long before the existence of bacteria was discovered. It was later found that 
fermented foods contain bacteria, mainly lactic acid bacteria (LAB) and 
bifidobacteria and these have since been extensively studied for their 
beneficial effects on human health. Probiotics are living bacterial food 
ingredients with beneficial effects on human health (Fuller, 1986). 
Bifidobacteria and LAB, especially lactobacilli, are commonly used as 
probiotics agents. In addition, specific dietary compounds have been shown 
to alter the metabolism or stimulate growth of beneficial groups of bacteria, 
such as inulin or fructooligosaccarides that stimulate the growth of 
bifidobacteria and lactobacilli in the gut (Van Loo, 2004). These compounds 
are collectively called prebiotics (Gibson & Roberfroid, 1995).  Both pre- 
and probiotics and have been implicated to be protective against several 
clinical complications, such as allergy development (Abrahamsson et al., 
2007), inflammatory bowel diseases (IBD; Sartor, 2004), irritable bowel 
syndrome (IBS; Kajander et al., 2008) and acute diarrhea (Canani et al., 
2007).  
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3 The microbiota and gut related disorders 
A balance between the host immune system and the commensal gut 
microbiota is crucial for maintaining health. When this balance is disturbed, 
the host–microbe relationship can progress towards a disease state. Although 
some members of the commensal gut microbiota protect our body from 
foreign infections, other members are partly responsible for several of the 
disorders within the gastrointestinal tract. For example, some microbes in 
the mouth are responsible for two of the most common bacterial infections 
in humans, namely caries and periodontitis. Moreover, the discovery of    H. 
pylori and its role in the development of gastritis, duodenal ulcers and gastric 
cancer gained large attention. In addition, the gut microbiota has been 
implicated to play an important role in several other disorders of the 
gastrointestinal tract, such as inflammatory bowel diseases (IBD), including 
Crohn’s disease (CD) and ulcerative colitis (UC), irritable bowel syndrome 
(IBS), as well as colorectal cancer (CRC) and allergies. How, when and to 
which extent the microbiota is involved in the mechanisms causing these 
diseases remains an enigma. The mechanisms are thought to be multifactorial 
for most, if not all disorders of the gastrointestinal tract, including host 
susceptibility, microbial factors and environmental triggers.  
 
In recent decades incidence rates of several of the immune dysfunctional 
disorders in the human gastrointestinal tract have increased dramatically 
(Guarner et al., 2006). This increase in autoimmune disease incidence is, 
however, only observed in developed countries. A high level of hygiene has 
been identified as one risk factor for developing allergies, IBD, type I 
diabetes, and multiple sclerosis (Guarner et al., 2006). The correlation 
between the modern hygienic lifestyle and the increase in allergies has given 
rise to the hygiene hypothesis, suggesting a link between decreased pathogen 
exposure and developing inflammatory disorders (Strachan, 1989). For 
example, there is supportive data, that carriage of helminths, a multicellular   21
worm parasite that is eliminated in western societies, might protect the host 
from developing immunological disorders (Guarner et al., 2006). However, 
an alternative interpretation suggests that disturbances of the intestinal 
microbiota occur due to an increased use of antibiotics and “Westernized” 
dietary habits that disrupt the mechanisms involved in the development of 
immune tolerance (Noverr & Huffnagle, 2004). There are many hypotheses 
regarding which microbial mechanisms are underlying these diseases. One is 
the “pathogen hypothesis”, where researchers have tried to correlate 
gastrointestinal disorders with infection of recognized pathogens. One 
example of a microbe that has been investigated as a potential invasive 
pathogen in gastrointestinal disorders is Mycobacterium avium subsp. 
paratuberculosis (MAP). For example, this bacterium has been implicated in 
CD development (McFadden et al., 1987; Yoshimura et al., 1987). Another 
hypothesis, suggests that breakdown of the balance between beneficial and 
harmful bacteria (dysbiosis) initiates an overly aggressive immune response 
(Tamboli et al., 2004), or leads to proliferation of toxin-producing bacteria, 
such as in the situation for Clostridium difficile mediated diarrhea (Pothoulakis, 
1996).   
3.1 Allergy and asthma 
There has been a constant increase of asthma and allergic diseases in western 
countries over the last few decades. Within any given country, asthma and 
allergies are more prevalent in urban than in rural areas (Guarner et al., 
2006). The assumptions underlying the hygiene hypothesis have resulted in 
a large interest in the study of the microbiota in individuals with allergy or 
asthma and such studies have revealed a high correlation between allergies 
and a disrupted microbial composition (Alm et al., 1999; Björksten et al., 
1999; Kalliomäki et al., 2001; Wang et al., 2008; Wickens et al., 1999). The 
hygiene hypothesis emphasizes the importance of the microbial composition 
that establishes in newborn infants (Strachan, 2000). By comparing the 
microbiota of infants that were only three weeks old, the microbial 
community composition was found to differ between atopic and non-atopic 
infants, mainly with higher proportions of bifidobacteria in the non-atopic 
infants. However, this difference in the microbial composition was not 
reflected when the children were three months old (Kalliomäki et al., 2001). 
Furthermore, the microbial diversity was significantly lower in infants with 
atopic disease compared with non-atopic disease (Wang et al., 2008). 
Differences in the gut microbiota have also been observed between Estonian 
(low prevalence of allergies) and Swedish infants (high prevalence of 
allergies), mainly with higher counts of lactobacilli and eubacteria in 
Estonian infants and instead higher counts of clostridia in Swedish infants   22
(Sepp et al., 1997). Interestingly, the Estonian infant microbiota reflected the 
microbiota of infants in Western European countries several decades earlier, 
when the prevalence of allergies was low in Western Europe (Sepp et al., 
1997). In addition, the non-allergic infants within these respective countries 
had higher counts of lactobacilli and bifidobacteria whereas higher counts of 
coliforms and Staphylococcus aureus were reported among the allergic infants 
(Björksten et al., 1999). This finding supported the hypothesis that beneficial 
properties of lactobacilli and bifidobacteria, commonly used as probiotics, 
were protective against allergy development. Probiotic bacteria, in particular 
lactobacilli, have shown encouraging effects in prevention of allergy 
development (Isolauri et al., 2000; Rosenfeldt et al., 2003; Viljanen et al., 
2005). An increased prevalence of lactobacilli and lactic acid bacteria was 
shown in the infant microbiota of anthroposophic children (Alm et al., 
2002). Children raised according to the anthroposophic lifestyle, for 
example Steiner school children, are a low risk group for allergy 
development. 
3.2 Inflammatory bowel disease 
Inflammatory bowel disease refers to chronic relapsing disorders of the 
intestinal tract with yet unknown etiologies. It is the collective term for a 
group of heterogeneous tissue reactions, with similar clinical behavior. The 
most familiar subtypes of IBD are CD and UC. CD can affect the whole 
intestinal tract and is characterized by discontinuous involvement of various 
portions of the gut, whereas UC is restricted to the colon and rectum and is 
generally characterized by a continuous inflammation of the large bowel. 
Heterogeneities in response to medication and clinical behavior within CD 
and UC have further divided it into distinct disease phenotypes. For 
example, CD can be classified into a few main phenotypes, with respect to 
the disease location. The classical phenotype is located in the terminal ileum, 
i.e. ileal CD (ICD). Inflammation located in the colon is referred to as 
colonic CD (CCD) and inflammation involving both ileum and colon is 
addressed as ileocolonic disease (ICCD). Less common but still present is 
inflammation of the upper intestinal tract in some individuals (Satsangi et al., 
2006).  
 
The highest incidence of IBD is in Northern Europe, the UK and North 
America (Loftus, 2004). An increasing rate of disease incidence during the 
past few decades has now started to stabilize. Instead, the prevalence in low 
incidence areas, such as Southern European countries, has started to increase 
(Baumgart & Carding, 2007). Genetics plays an important role for the 
disease prevalence with higher concordance rates (both are sick) in   23
monozygotic twins than in dizygotic twins with CD (approximately 50% 
versus <10%). For UC the genetic factors are not as strong as for CD, 
shown with lower concordant rates in both mono- and dizygotic twins 
(approximately 15% and <5% respectively) (Orholm et al., 2000; Thompson 
et al., 1996; Tysk et al., 1988). Still, a large number of monozygotic twins 
are discordant for the disease (one is sick and one healthy), which 
emphasizes that other factors in addition to genetic predisposition play an 
important role in disease prevalence. To date, a number of environmental 
factors have been identified to be important for relapse of the disease. The 
most evident of these is smoking cigarettes, and this is directly associated 
with an aggravation of the disease, and acceleration of the need for surgery 
in patients in remission (Baumgart & Sandborn, 2007). Interestingly, 
smoking has the opposite effect in UC patients. Other factors, such as diet 
and childhood infections have been associated with IBD but data are 
conflicting (Loftus, 2004).  
 
There are several lines of evidence that argue for a microbial involvement in 
the disease etiology: 1) inflammation occurs in the regions with the highest 
bacterial densities, 2) diversion of the fecal stream induces clinical remission 
of active CD, however disease relapses shortly after the bowel continuity is 
restored (Harper et al., 1983), 3) germ free animals do not develop colitis 
(Sartor, 2003), 4) a subset of CD patients have polymorphisms in genes that 
encode receptors that recognize bacterial antigens (Ahmad et al., 2002), 5) 
antibiotics and probiotics have shown therapeutic efficacy in IBD patients 
(Sartor, 2004), 6) the epithelial barrier is leaky with defects in mucus 
production in patients with IBD (Swidsinski et al., 2007), 7) decreased levels 
of antimicrobial peptides (alpha defensins) have been demonstrated in ileal 
tissues from a subset of CD patients (Wehkamp et al., 2005) and 8) a large 
number of studies have reported an altered bacterial composition and higher 
bacterial loads in IBD patients compared with healthy individuals (Baumgart 
et al., 2007; Frank et al., 2007; Kleessen et al., 2002; Seksik et al., 2003; 
Swidsinski et al., 2002; Swidsinski et al., 2005).  In addition, the severity of 
the disease correlates with the bacterial density found in the intestinal 
mucosa (Swidsinski et al., 2002). 
 
There are two main hypotheses of how microbes can contribute in the 
development and progression of IBD. The search for a pathogen, 
responsible for the disease was originally focused on MAP. This bacterium, 
or traces of it, has been identified in blood and tissues of IBD patients 
(McFadden et al., 1987; Yoshimura et al., 1987) and furthermore it has been 
shown to be responsible for Johne’s disease, a disease with clinically similar 
symptoms in cattle (Greenstein, 2003). However, attempts to detect MAP in   24
CD tissues have resulted in conflicting and inconsistent findings (Chiodini, 
1989). Therefore, it was postulated that MAP infection could be responsible 
for CD in a subset of patients that were susceptible or that this organism may 
selectively but accidentally colonize the ulcerated mucosa of CD patients but 
not initiate inflammation. Currently, most recent publications do not 
specifically point out MAP as a causal agent in CD, however its role in CD 
is neither excluded (Sartor, 2005).  
 
Several studies have identified a higher prevalence of enterobacteria and in 
particular E. coli in mucosal tissues from IBD patients (Baumgart et al., 2007; 
Darfeuille-Michaud et al., 1998; Kotlowski et al., 2007; Swidsinski et al., 
2002). Most attention as been focused on adherent invasive E. coli (AIEC), 
that was isolated from and within ileal tissues of CD patients (Darfeuille-
Michaud et al., 1998). This bacterium has been found to persist and multiply 
within macrophages (Baumgart et al., 2007). Furthermore, it has been 
reported almost exclusively localized to ileal tissues from CD patients with 
the ileal disease phenotype. Moreover, a recent study by Mpofu et al. 
(2007), showed that supernatants from MAP cultures impaired the ability of 
adherent monocytes and monocyte-derived macrophages to kill phagocyted 
E. coli (Mpofu et al., 2007) and that could explain the increased prevalence 
of E. coli attached to and within the epithelia.  
 
There have also been reports of an imbalance (dysbiosis) between beneficial 
and detrimental bacteria in the intestinal microbiota that is correlated to CD 
(Baumgart et al., 2007; Manichanh et al., 2006; Scanlan et al., 2006; Seksik et 
al., 2003). The most prevalent observation is a reduction in the diversity of 
Firmicutes in CD patients, with reduced numbers of specific members of the 
microbiota, mostly within the Clostridium leptum ( Clostridium cluster IV) 
group (Baumgart et al., 2007; Frank et al., 2007; Manichanh et al., 2006; 
Scanlan et al., 2006). This group is thought to be functionally important as 
one of the major producers of SCFA, particularly butyrate, which has been 
shown to act as a fuel and inflammation repressor for the colonic epithelial 
cells (Pryde et al., 2002). This observation has been supported by the 
observation of decreased fecal levels of acetate and butyrate in CD patients 
(Marchesi et al., 2007; Takaishi et al., 2007).  
 
3.3 Gastric cancer 
Gastric cancer is a worldwide problem and one of the leading causes of 
deaths due to cancer, although its incidence in western societies has been 
decreasing in recent years (Lochhead & El-Omar, 2007). The major known   25
risk factor for developing gastric cancer is H. pylori. This bacterium by itself 
is classified as a carcinogen by the Agency for Research into Cancer. 
However, only a small percentage of the individuals that carry this 
bacterium will develop cancer, suggesting that other factors, such as host 
susceptibility, dietary, lifestyle factors or other bacteria residing in the 
stomach may contribute towards cancer development. Persistent 
colonization of H. pylori can lead to divergent responses. Most carriers will 
develop mild pangastritis, a condition that does not alter the gastric 
physiology and without disease symptoms (Smith et al., 2006). However, in 
some individuals, persistent colonization will progress into a disease state. 
Antral predominant gastritis is associated with increased production of gastric 
acid, and an increased risk in developing duodenal ulcer disease, but instead 
a low risk in developing gastric cancer (Hansson et al., 1996). By contrast, 
corpus predominant gastritis, leads to a reduced production of gastric acid 
and increased risk in developing gastric cancer (Uemura et al., 2001). An 
altered physiology with a reduced capacity for acid secretion allows survival 
and proliferation of bacteria that are normally not thought to survive the 
acidic conditions of the stomach. The role of these invaders is not known 
but it is hypothesized that they have the capacity to convert nitrite to 
carcinogenic N-nitroso compounds and trigger the release of reactive 
oxygen species (Blaser & Atherton, 2004). Furthermore, bacterial 
overgrowth of the stomach and the small bowel can contribute to 
malabsorption, diarrhea, and possibly to bacterial translocation of the 
epithelial layer (Husebye, 2005). The bacterial composition of the stomach 
has been studied in patients using acid-reducing drugs (Adamsson et al., 
1999; Mowat et al., 2000; Sanduleanu et al., 2001), but rarely in gastric 
cancer patients (Sjöstedt et al., 1988), and those studies have been restricted 
to detection of the culturable fraction of the stomach microbiota. The 
current knowledge of the gastric microbiota in patients using acid reducing 
drugs has revealed a predominance of the species normally found in the 
upper respiratory tract.  
3.4 Colorectal cancer 
A western diet, comprising a high intake of fat and animal protein but low 
fiber content is associated with a higher risk in developing colon cancer, 
compared to a Japanese diet and vegan diet which are associated with a low 
risk of developing colon cancer (Hayashi 2002). However, Japanese who 
adopt a westernized diet, develop colon cancer more frequently (Finegold 
1978). Case control studies have shown that dietary fat and high 
consumption of red meat, in particular processed meat, are associated with 
an increased risk of developing colorectal cancer (CRC; Guarner 2006). In   26
contrast, high intake of fruits and vegetables and whole grain cereals, fish 
and calcium is associated with a decreased risk. Meat is a rich source of 
sulphur, which promotes growth of sulphate reducing bacteria (SRB). This 
group of bacteria produces hydrogen sulphide, a toxic compound that can 
suppress butyrate utilization, inhibit the synthesis of mucus and methylation 
of DNA (O'Keefe, 2008). Gut bacteria exhibit a number of characteristics 
that can contribute to development of CRC. For example, they are able to 
produce genotoxic compounds that can activate pro-carcinogens to DNA 
reactive agents. Animal models have shown that colon cancer not was 
developed in germ free animals whereas 70% of the animals in the same 
model with a gut microbiota developed colonic tumors (Kado et al., 2001). 
A number of bacterial species have been associated with CRC but without 
any consistency. For example, increased numbers of Bacteroides have been 
associated with an increased risk for CRC (Hill et al., 1971; Moore & 
Moore, 1995). Also, increased numbers of both Clostridium and Lactobacillus 
have been found in individuals with CRC (Kanazawa et al., 1996). By 
contrast, Lactobacillus spp have been associated with a reduced risk (Moore & 
Moore, 1995). Streptococcus bovis have been implicated in colonic neoplasia, 
and antigens extracted from its cell wall have provoked proinflammatory 
responses in animal models (Biarc et al., 2004; Ellmerich et al., 2000). 
   27
4 Methods to study the gut microbiota 
4.1 Cultivation versus Molecular approaches 
Traditionally, microbes in the gastrointestinal tract have been studied using 
cultivation-based techniques. The great advantage with cultivation is that 
isolates can be recovered and further studied for their ability to utilize 
different substrates and other physiological parameters. However, cultivation 
suffers from several drawbacks. It is very labor intensive and does not give a 
representative picture of the intestinal microbiota. Only a small proportion 
(approximately 20 %) of the microbes residing within our intestinal system 
can be cultivated with the approaches currently available (Eckburg et al., 
2005). This number is even lower for other ecological niches, such as soil, 
where it is estimated that only 0.1-10% of the bacteria can be cultivated 
(Torsvik et al., 1998). In recent decades development of molecular 
approaches has enabled us to bypass the necessity for cultivation, thereby 
opening a new window to explore the world of microbes, however, mostly 
viewed behind the screen of a computer. The most common methods rely 
upon analysis of the prokaryotic 16S ribosomal RNA gene that encodes part 
of the small subunit of the ribosome. This gene, approximately 1.5 kb long, 
is present in all prokaryotes in various copy numbers and has enough 
sequence conservation for accurate alignments and at the same time enough 
sequence variability to detect differences between different species. This has 
therefore been used as a tool to determine the phylogenetic relationships 
between different microorganisms. The widespread use of the 16S rRNA 
gene in microbial ecology has provided an extensive public DNA database, 
including close to 500,000 16S rRNA gene sequences. The sequence 
database is growing with a tremendous speed.  
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4.2 Microbial community fingerprinting 
Microbial community fingerprinting is the collective term for a number of 
molecular methods that have recently been developed to study the 
composition of microbial communities in different environments. Unifying 
for all molecular fingerprinting approaches is that they rely on multi-
template PCR reactions for assessment of microbial community structures, 
or “fingerprints”. Depending on the approach used, they have potential for 
high throughput, are relatively cheap and not too laborious. However some 
methods lack resolution and are limited in their identification abilities. 
Nevertheless, these approaches are very useful for studying the dynamics of 
microbial communities due to different treatment or temporal effects or for 
comparisons between groups of individuals. These fingerprinting methods 
have been used extensively in the field of environmental microbial ecology 
and more recently to provide essential knowledge of factors contributing to 
the dynamics and composition of the gut microbiota. 
 
4.2.1 DGGE/TGGE 
One of the most common fingerprinting approaches to assess the structure of 
the intestinal microbiota is denaturing gradient gel electrophoresis (DGGE), 
or temperature gradient gel electrophoresis (TGGE). These methods 
separate multitemplate PCR products as bands on gels according to GC 
content, dependent on melting behaviors of the amplicons as they migrate 
through the gels (Figure 3). The amplicons become denatured according to 
their GC content during gel migration. In DGGE, the denaturing agent is 
commonly a mixture of urea and formamide, while TGGE uses a 
temperature gradient. The resulting banding patterns on gels can be 
compared visually on the gel or analyzed by cluster analysis. One advantage 
of this approach is that bands of interest can be excised and sequenced to 
obtain information about the species they represent. Muyzer et al. (1993), 
was the first to use DGGE to obtain fingerprints of complex microbial 
communities in soil samples (Muyzer et al., 1993). More recently this 
method has been used to monitor the temporal stability of the microbiota in 
health and disease (Scanlan et al., 2006; Zoetendal et al., 1998), including 
impacts of diet, antibiotics and probiotics (McCracken et al., 2001; 
Vanhoutte et al., 2006). Furthermore, it has been used to assess the microbial 
composition at some other sites of the body, such as the stomach (Monstein 
et al., 2000) and mouth (Zijnge et al., 2006).     29
 
Figure 3. Flowchart of four PCR-based methods for microbial community fingerprinting, A) 
T-RFLP, B) DGGE/TGGE, C) Cloning and sequencing, D) 454-FLX pyrosequencing. (A) 
In T-RFLP, PCR amplification with a fluorescently labeled primer (I) and restriction 
digestion of the amplicons provides a restriction pattern (II) where only the terminal labeled 
fragments will be detected during electrophoresis and provides a community fingerprint (III). 
(B) In DGGE/TGGE, a primer tagged with a GC clamp (I) prevents complete denaturation 
of amplicons in gel electrophoresis (II) where amplicons are separated according to GC 
content during migration against a thermal (TGGE) or chemical gradient (DGGE). (C) In 
cloning and sequencing, PCR amplicons are cloned into plasmid vectors (I) and transformed 
into bacteria (II) that are multiplied on agar plates (III). Plasmids are recovered from the 
clones and inserted fragments are sequenced (IV). (D) In 454-FLX pyrosequencing, the 
amplicon is tagged with adaptors, (a and b). In addition, a sample specific barcode (t) allows 
tracking of each read back to its original sample (I). The fragments are bound, though the 
adaptor sequences, to oligo-nucleotide coated beads, favoring one fragment per bead. 
Fragments are emulsified in a micro reactor (II) and the amplified DNA is sequenced using 
pyrosequencing (III), which is performed by flowing nucleotides over wells and measuring 
light emission (III) that gives rise to a sequence (IV).        30
4.2.2 T-RFLP 
Terminal-restriction fragment length polymorphism (T-RFLP) is another 
powerful fingerprinting approach that has been widely used in microbial 
ecology (Jernberg et al., 2007; Kitts, 2001; Liu et al., 1997; Wang et al., 
2008)(Papers I-IV). In this method the PCR product is end labeled with a 
fluorescent dye. Restriction digestion of the amplicons provides a restriction 
pattern, but only the terminal labeled fragment will be detected during 
electrophoresis based on its fluorescence that is detected by an automated 
sequencer. Sequence polymorphisms between species provide 
heterogeneous terminal fragment lengths (TRFs) and their corresponding 
lengths (base pairs) are determined based on a standard (Figure 3). The 
intensity of the fluorescence will also be registered and reflects a quantitative 
measure of abundances of the individual TRFs. However, this quantitative 
measure should only be considered as relative quantitation, i.e. relative 
abundance. The output raw data from T-RFLP analysis is visualized in an 
electropherogram. The electropherograms can be compared visually 
between samples, however with increased risk for misinterpretations of the 
data due to variations in running conditions, amplicon amounts, etc. 
(Hayashi et al., 2002; Sakamoto et al., 2003). It is more appropriate to 
normalize the data by applying size and abundance threshold values. 
Relative abundances of individual TRFs can be calculated as percent areas 
by summing the total TRF peak area and dividing each individual TRF by 
the sum of TRFs. In this way the comparisons between samples are not 
restricted by the amount loaded on the gel or into the capillary. In addition, 
by constructing a consensus profile of technical replicates, false positive peaks 
can be excluded and biases introduced by PCR decreased. T-RFLP can be 
used to visualize diversity (of TRFs or of dominant populations; see below), 
structure and dynamics of the microbiota in a statistically adequate manner. 
The method has been shown to be highly reproducible (Lueders & 
Friedrich, 2003; Osborn et al., 2000). T-RFLP has been successfully used, 
for example, to monitor changes in the microbiota due to antibiotic 
administration (Jernberg et al., 2007), to assess the diversity of fecal microbial 
communities in allergic infants (Wang et al., 2008) and the community 
structure of the oral microbiota (Sakamoto et al., 2005). In addition, it has 
constituted a methodological backbone in this thesis, used in all Papers (I-
IV). One weakness of T-RFLP is that the data does not rely on 
identification alone since the direct link between TRFs and sequence data is 
lacking. Another disadvantage is that one TRF can potentially originate 
from several phylogenetically unrelated species. This method is more 
suitable for rapid comparisons of microbial community compositions in 
different samples. If the goal is to still try to identify the species 
corresponding to a specific TRF there are usually two options: 1) to use   31
 information from multiple enzyme digestions in parallel and to compare the 
terminal restriction patterns from the different enzymes to a database 
(Edlund et al., 2006; Marsh et al., 2000). This approach introduces some 
uncertainties due to structural differences between the fluorophors attached 
to the internal standard and the sample DNA fragments that may introduce a 
difference in the true and observed fragment lengths (Kaplan & Kitts, 2003). 
2) Another option is to create a clone library to find sequences 
corresponding to specific TRF lengths when digested in silico. In addition, 
T-RFLP analysis of the clones in the library can first be used to find out 
which clones should be sequenced to match a specific TRF of interest in a 
T-RFLP profile (Papers II and III). However representatives of TRFs with 
low abundances are usually hard to track in clone libraries, due to the 
requirements of screening many clones to detect rare sequences.  
4.2.3 Cloning and sequencing 
Cloning and sequencing of 16S rRNA genes, (Figure 3), yields a lot of 
information, depending on the number of clones sequenced, but is time 
consuming and associated with high costs. The usual dilemma in cloning 
surveys is to select between high resolution allowing in depth analysis from a 
few samples, or lower resolution allowing more samples to be included in 
the analysis. A few large scale-cloning surveys have provided valuable 
information of the microbial diversity at different anatomical sites of the 
body (Aas et al., 2005; Bik et al., 2006; Eckburg et al., 2005; Pei et al., 
2004).   
4.2.4 454 pyrosequencing 
Recent methodological breakthroughs have enabled large scale cloning 
surveys that permit in depth analysis of each sample as well as a large set of 
samples. Recently, 454 pyrosequencing has been proposed as a new 
powerful technique for assessment of complex microbial communities 
(Margulies 2005). In this technique, DNA fragments from e.g. a 
multitemplate PCR are bound to beads under conditions that favor one 
fragment per bead. A PCR amplification step occurs in emulsified micro 
reactors surrounding the beads (Figure 3). The amplified DNA can then be 
sequenced using the light emission technique pyrosequencing (Ronaghi et 
al., 1998). This approach provides a tremendous number of DNA 
sequences, usually several hundred thousand sequences per run. The read 
length using this type of technology was originally very short (approximately 
50-100 bp), but recent improvements (i.e. 454-FLX) have increased the 
read length and it is now possible to obtain approximately 200-500 base pair 
long sequence reads. By using a sample specific barcode on one of the 
primers, each read can be tracked back to its original sample. Using this   32
 approach several samples can be run in parallel on a 454 picotiter plate. This 
technique is expected to be more widely applied for many types of 
environmental samples, and we were the first to our knowledge to use the 
454-FLX method for the intestinal microbiota (manuscript in preparation). 
Although this approach is not subjected to cloning bias it still has the biases 
introduced by PCR. In addition, this is currently a very expensive approach 
due to the associated running costs and it is challenging because the large 
amounts of data require extensive bioinformatics skills and processing. 
Despite these disadvantages, many microbial ecologists feel that this sort of 
technique will eventually surplace many of the other fingerprinting methods 
currently in use, in particular when costs eventually decrease. 
4.3 FISH 
Direct quantification of the number of bacteria in a sample can be 
performed by Fluorescent In Situ Hybridization (FISH). This method relies 
on detection of bacteria using fluorescently labeled oligonucleotide probes. 
The fluorescently labeled bacteria are usually detected by epiflourescent 
microscopy, confocal laser microscopy or flow cytometry (Zoetendal et al., 
2004). Depending on the selection of probes, FISH can be used to detect 
bacteria at different phylogenetic levels. It is not based on PCR and thereby 
free from biases introduced by PCR or DNA recovery. It is however 
dependent on reliable sequence data, and laborious if identification at the 
species level is required. In addition, only a few probes can be used per 
analysis. This approach has been used in several studies to quantify specific 
groups of bacteria in both fecal samples as well as in biopsies (Mueller et al., 
2006; Swidsinski et al., 2002).  
4.4 Quantitative PCR  
Another way for direct quantification of the number of bacteria in a sample 
is to use quantitative PCR (qPCR). This method uses a chemiluminscent or 
fluorescent reaction to determine the kinetics of product accumulation 
during PCR amplification with specific primers for a specific group or 
species of bacteria. It is then possible to use the product accumulation rate 
curves to back calculate to the number of original target molecules in a 
sample. This method is limited by the specificity of the primers used during 
PCR and has mainly been used to detect and quantify bacteria at the genus 
or phylum level. The 16S rRNA gene is commonly used as a target 
molecule however, due to heterogeneous gene copy numbers in some 
species, quantification based on 16S rRNA gene copies can be misleading. 
One way to get around this problem is to amplify other genes that are    33
present in single copies per genome, such as some “housekeeping genes” or 
to amplify a functional gene specific for a given group or species to increase 
specificity (Paper III).  
4.5 G+C fractionation 
Percent guanine + cytosine (%G+C) profiling is another approach for 
assessment of complex microbial community structures, such as that found in 
the gastrointestinal tract (Paper II). This method relies on separation of 
bacterial chromosomes in a density gradient based on differences in their 
%G+C contents, imposed by an AT-dependent DNA-binding dye 
(Apajalahti et al., 1998). With a differential ultracentrifugation step, the 
chromosomal DNA can be fractionated and the %G+C content, represented 
by each gradient fraction, determined based on DNA standards with known 
%G+C composition. The advantage with this method is that it is 
independent of prior sequence information (e.g. primer and probe 
sequences) and thus free of biases such as those related to PCR and cloning. 
Furthermore, the %G+C fractionation offers the opportunity to further 
analyze bacterial genomes with a defined interval of GC content (Kassinen et 
al., 2007). The disadvantage is a poor resolution and no possibility to 
identify community members, without additional PCR or cloning steps. 
4.6 Method considerations  
As in all analyses there are a number of limitations and biases along the road 
that are important to keep in mind when it comes to interpretation of data. 
A good study design is of great importance to be able to draw powerful 
conclusions. For example, the sample type, number of samples, 
methodological approach, environmental data, etc. are factors that could be 
highly important to take into consideration before starting a study. For 
studies of the human gut, it is valuable to have knowledge about external or 
host related factors that might affect the gut microbial composition and to 
use this information when designing studies to reduce the number of 
confounding factors when possible.  
4.6.1 Sampling 
Sample origins and types should be carefully considered depending on the 
scientific question to be addressed. For example, some studies have shown 
differences in the luminal and the mucosa-associated microbiota in the gut 
(Eckburg et al., 2005; Lepage et al., 2005; Sanduleanu et al., 2001; Zoetendal 
et al., 2002). As mentioned above, in some studies the fecal microbiota has 
been shown to differ from the colonic microbiota found on mucosal   34
biopsies. When studying intestinal diseases, it is often stated that the mucosal 
microbiota are more relevant to study due to their closer interaction and 
ability to crosstalk with the host epithelial cell layer. However, mucosal 
samples are harder to obtain than fecal samples and sampling is invasive to 
the human host. By contrast, fecal samples are non- invasive, easier to 
collect, and thereby more feasible for use in dynamic studies of the 
microbiota. Another consideration to take into account is that biopsy 
collection is usually preceded by a washout of the bowel. However, this 
procedure might introduce a biased view the mucosa-associated community 
when comparing with a fecal sample or an unwashed biopsy. In one study, it 
was shown that the fecal microbiota differed from its original composition 
after colonoscopy in three out of five patients. This effect was observed 6-8 
weeks after colonoscopy and it is not known how long this disruption of the 
fecal microbiota lasts (Mai et al., 2006). 
4.6.2 DNA extraction 
One of the bottlenecks that is of critical importance in molecular studies of 
the human gut is the extraction and purification of DNA from the fecal and 
biopsy samples. There are numerous extraction protocols available to purify 
DNA from different types of matrixes. Several different extraction methods 
have been compared (McOrist et al., 2002; Scupham et al., 2007), but 
without a consensus result. Use of bead beating is generally thought to be 
most suitable for efficient lysis of Gram-positive microbes (Zoetendal et al., 
2001b). However, the bead beating time needs to be optimized so that it is 
long enough to disrupt the cell wall of hard to lyse cells, but not too long so 
as to shear DNA. In addition, it is of critical importance to have a good 
DNA quality for downstream analyses, without PCR inhibiting agents, 
which are common in fecal samples. Finally, sample replication is important 
to ensure reproducibility of the extraction method. Therefore, sample 
extractions are commonly performed in two or more replicates.  
 
4.6.3 PCR amplification 
There are a number of biases and limitations associated with multitemplate 
PCR reactions. The first critical step is selection of PCR primers. The 
constantly expanding databases of 16S rRNA genes have revealed that 
primers considered as “universal” exclude many sequences. The specificity 
of the primers also deserves careful attention. For example, when mucosal 
biopsies are studied the bacterial universal primers should not target or bind 
to the human genome. Furthermore, the numbers of PCR cycles has been 
shown to reflect the bacterial diversity in clone libraries, with a higher 
diversity correlating with a lower cycle number (Bonnet et al., 2002). In   35
 addition, the template to product ratio can be affected by the number of 
PCR cycles (Polz & Cavanaugh, 1998). PCR based approaches will not 
reveal any information about whether the bacteria that are detected are alive 
or dead. In one study it was shown that only two thirds of the cells 
recovered from feces are alive and the rest are dead (Ben-Amor et al., 2005).  
 
One must keep in mind that despite all the technical biases and limitations 
these approaches might introduce, as long as the same reagents and 
conditions are used for the sample sets, that molecular fingerprinting 
approaches are very powerful, reproducible and rapid tools for 
determination of structural changes in microbial communities. For example, 
T-RFLP was found to be highly reproducible and in direct proportion to 
the abundance of the sample template (Clement & Kitts, 2000; Dunbar et 
al., 2000). 
4.7 Statistical approaches in community analyses 
4.7.1 Multivariate data analysis  
The use of molecular methods for analyzing bacterial communities from 
different environments has increased extensively during the past decade. 
These methods provide large sets of data that are commonly interpreted 
with multivariate statistical methods. There is no single standard method for 
examining differences in microbial community structure. In general, data 
from fingerprinting approaches are analyzed by ordination approaches, such 
as principal component analysis (PCA; Papers I and II; Jernberg et al., 
2005; Kaplan & Kitts, 2004; Wang et al., 2004), correspondence analysis 
(CA; Edlund et al., 2006), and non-metric multidimensional scaling (nMDS; 
Rees et al., 2004). The main use of these multivariate methods is to reduce 
the complexity in the dataset and to identify patterns that unify samples. For 
example, two samples with high agreements in their species compositions 
will group tightly together whereas two samples that have a dissimilar species 
composition will be separated in ordination space. Statistical significance of 
differences in species composition between clusters from ordination is 
usually assessed with permutation tests (Papers II and IV). In regular linear 
models, the reference distribution for hypothesis testing can be derived 
mathematically from the assumptions of the test. In a permutation test, the 
reference distribution is instead determined from the obtained data by a 
repeated shuffling of the samples (Legendre & Legendre, 1998).       
 
Cluster analysis is also commonly used for data generated from molecular 
fingerprints (Blackwood et al., 2003; Kitts, 2001; Sakata et al., 2005). In   36
cluster analysis, pair-wise comparisons of samples are calculated as distances 
and sorted according to the calculated value of the distance. There are 
several different ways to describe the similarity of a pair of samples, and 
thereby a large number of distance coefficients that can be used for these 
calculations (Legendre & Legendre, 1998). Jaccard, Dice or Sorensen 
coefficients are appropriate for presence/absence analysis, but ignore species 
abundance (Papers I and II). Euclidean distance, the distance coefficient in 
PCA, is not considered to be appropriate for datasets with a large number of 
zeroes (Legendre & Legendre, 1998), which is commonly encountered in 
T-RFLP analysis. Instead, the Bray Curtis index is more suitable and is 
thought to give a good representative picture of the structural differences of 
the data (Papers III and IV).  
 
The use of multivariate tools for interpretation of large sets of data has 
become invaluable to identify gradients or subgroups within a sample 
cohort. However, the complex nature of biological data and differences in 
sampling designs should be taken into account prior to selection of the 
analysis method. There is a danger in only relying on the observation from a 
multivariate statistical approach without further confirmation. Different 
methods sometimes give inconsistent results because they are used 
incorrectly.  
4.7.2 Diversity indices 
It is generally thought that a high diversity, including microbial diversity, is 
beneficial for an ecosystem providing a higher resilience to ecological 
disturbances (Bäckhed et al., 2005). Diversity is typically described in terms 
of species richness and evenness.  Richness reflects the number of species in 
a system but does not take their relative proportions into consideration. 
Evenness reveals the distributional composition of species in a community 
by including their relative abundances. There are a number of different 
indices to describe diversity. Simpson’s index of diversity (D) is commonly 
used, and incorporates both species evenness and richness (Legendre & 
Legendre, 1998). Another index to assess diversity is Shannon’s index, 
(Legendre & Legendre, 1998) which is divided into a richness index (H) and 
equitability index (E). Microbial diversity assessment based on T-RFLP or 
DGGE/TGGE analysis is not a measure of “true” diversity, because only the 
most dominant members of the community are assessed. This must therefore 
be taken into account when these tools are used for estimations of microbial 
diversity. However, these methods can provide a relative diversity measure 
for comparisons between samples and serve as a diversity indicator. 
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5 Results obtained during the project 
5.1 Lifestyle influences of the microbiota 
Some lifestyles, such as an anthroposophic lifestyle and living on a farm are 
associated with a low risk in developing asthma and allergies (Alm et al., 
1999; Braun-Fahrländer et al., 2002). Certain characteristics of the 
anthroposophic lifestyle, such as a restrictive use of antibiotics, antipyretics 
and vaccinations, have been epidemiologically associated with a reduced risk 
for allergies (Flöistrup et al., 2006). This lifestyle also includes certain dietary 
habits, such as a high intake of organic and biodynamic foods that often 
include naturally fermented vegetables. It was previously shown that infants 
in anthroposophic families had a higher prevalence of lactic acid bacteria 
than other infants (Alm et al., 2002). Therefore, one aim of this study was to 
investigate if an anthroposophic lifestyle impacted the intestinal microbiota 
in children. Another interesting group to study is children raised on farms 
because these children are consistently exposed to elevated levels of 
endotoxins and mould components (Schram-Bijkerk et al., 2005). In 
addition, the farming lifestyle includes a number of features that may 
influence the microbial composition in the gut, such as a diet often 
including unpasteurized dairy products and exposure to animals and their 
stools. In Paper I, the fecal microbiota was studied in 90 children from 
anthroposophic families, selected from their attendance in Steiner schools 
that subscribe to this lifestyle philosophy, or children growing up on farms. 
In addition, control groups for the respective lifestyles were included, i.e., 
living in a similar environment but not exhibiting these lifestyles. The 
samples derived from an epidemiological multicenter study, PARSIFAL 
(Alfvén et al., 2006), with the aims to identify factors in the anthroposophic 
and farming lifestyle that contribute to the protection against allergy   38
development. Fecal microbial profiles w e r e  a s s e s s e d  u s i n g  T - R F L P  f o r  
investigation of the microbial compositions in these groups.  
 
5.1.1 Microbial diversity associated with lifestyle factors 
Multivariate statistics revealed no significant differences in the gut microbial 
communities between the groups of children. Also, it was not possible to 
correlate the TRF profiles to any of the explanatory variables, such as 
lifestyle characteristics, age, gender or geographical origin, provided from 
the questionnaire data. However, when the bacterial diversity was 
calculated, based on the richness and evenness of TRFs in the T-RFLP data, 
significant differences were obtained in comparisons between groups. Most 
prominent was a higher bacterial diversity in children from anthroposophic 
families (Steiner school children) and a lower diversity in farm children (P = 
0.0001; Figure 4). Several characteristics associated with the respective 
lifestyles correlated with the observed differences in diversity (Figure 4). 
However, it was not possible to identify a specific factor responsible for a 
particular increase or decrease in diversity.  
 
Some general correlations to particular factors can however be made. For 
example, antibiotics are known to have a large potential to disrupt the 
microbial composition in the gut, and we found that the children that never 
used antibiotics at all had a higher microbial diversity than the ones that had 
taken antibiotics. In addition, the dietary regimes in general differ largely 
between these groups, as mentioned above. These dietary discrepancies may 
also contribute to the measured differences in gut bacterial diversity between 
these lifestyles. Interestingly, the factors that correlated with the highest and 
lowest bacterial diversity have epidemiologically been identified to be 
protective against allergy and asthma development (Alfvén et al., 2006; 
Flöistrup et al., 2006).    
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Figure 4. Bacterial diversity based on T-RFLP data in fecal samples collected from 90 
children raised according to different lifestyles. The line in the center represents median 
diversity for all sampled individuals. The size of each bar represents the deviation of the 
median value for each factor in comparison with the median for the whole sample set. 
Factors associated with specific lifestyles (i.e. anthroposophic, respective farming lifestyle) are 
highlighted in dark grey.  
 
5.1.2 Impacts of microbial diversity 
In general, it is considered that a high diversity is beneficial for an 
ecosystem, enabling the community with a greater ability to respond to 
disturbances (Bäckhed et al., 2005). One can hypothesize that a higher 
microbial diversity in infants would result in a broader range of immune 
triggering compounds that would be beneficial in shaping the immune 
system. In support of this hypothesis, a reduced diversity was observed in the 
fecal microbiota of one-week-old infants with atopic eczema compared with 
non-atopic infants (Wang et al., 2008). Interestingly, in Paper I, the lowest 
measured diversity correlated with the farming lifestyle and associated 
factors, which is thought to be protective against allergy development. This   40
result suggests that the microbial diversity is not crucial, as long as the 
microbial consortia present in the intestinal tract are able to retain ecosystem 
function. Another possibility is that the microbial diversity may play a more 
crucial role during the first weeks of life. Kalliomäki et al. (2001), reported 
differences in the microbiota of three weeks old atopic and non-atopic 
infants. However, these differences could not be reproduced when the 
infants were three months old and in Paper I the children were older (5-
13).   
 
Despite inter-individual differences in the microbiota between individuals 
analyzed in Paper I, some TRFs were common for all subjects. For 
example TRFs 223 and 272 were present in 89/90 and 90/90 subjects 
respectively. In Paper I, we postulated that the bacteria represented by 
these TRFs could represent core residents of the intestinal microbiota. In 
addition, these TRFs had higher abundances in the farm children. The 
attempts to identify the bacterial species that corresponded to these TRF 
sizes relied only on the existing sequences deposited in public databases and 
were not conclusive. However, in Paper III, correlation between TRF data 
and sequence data from mucosal biopsies indicated that these TRFs most 
likely corresponded to the Firmicutes phylum, and in particular TRF 223 was 
specifically correlated to sequences related to Faecalibacterium prausnitzii. This 
bacterium is a producer of butyrate and could represent a core bacterial 
resident of the intestinal tract. This finding supports the idea that keystone 
species may obviate the need for a high microbial diversity (Ley et al., 
2006a). 
5.1.3 Lactic acid bacteria–like microbiota 
The dietary habits associated with the anthroposophic lifestyle include 
naturally fermented foods preserved with lactobacilli. Studies of probiotics 
including lactobacilli have shown promising effects of these bacteria in 
prevention of allergies (Abrahamsson et al., 2007; Kukkonen et al., 2007). 
Therefore, in Paper I primers targeting lactic acid bacteria were used in the 
T-RFLP approach. In eight out of the 90 samples, it was not possible to 
obtain a PCR product, presumably as the LAB were under the detection 
limit in those samples. Interestingly, none of these negative samples derived 
from the Steiner school children. The obtained profiles for the LAB-like 
community divided the individuals into two groups, dependent on different 
dominant TRFs. In 30% of the individuals a TRF corresponding to 
Eubacterium biforme or E. cylindroides dominated the profile. By contrast, 70% 
of individuals were dominated by a TRF that correlated with a previously 
uncultured bacterial clone derived from the intestinal tract. Interestingly, 
individuals with both TRFs were negligible. The divergent prevalence of   41
these TRFs was not possible to correlate to specific lifestyle factors, yet, with 
one exception, the presence of the TRFs corresponding to the eubacterium 
clones were more prevalent among the farm children and consumers of farm 
milk. The biological significance of the prevalence of different species, 
targeted using this approach is however not known. Although lactobacilli 
were detected the TRFs that correlated to Lactobacillus spp. were not among 
the most dominating ones, suggesting that the lactobacilli were present in 
lower abundances in the general community.  
 
5.2 The microbiota of twins with Crohn’s disease 
Genetic factors are important for influencing susceptibility for development 
of CD. Several susceptibility loci have been identified in the human genome 
(Weersma et al., 2007). Importantly, studies of identical twins have revealed 
that although host genetics is important, other factors are also involved in 
CD development, such as stimuli from gut microbes.  Because identical 
twins have an identical genetic makeup, and often comparable dietary and 
lifestyle habits, they are an model system for dissection of other factors that 
can influence CD. In particular, study of twins that are discordant for the 
disease (one is healthy and one has CD), provides a means to untangle the 
respective contributions of genetics from other factors, since the twin pairs 
provide each other’s genetically matched control. Numerous studies have 
investigated the composition and dynamics of the intestinal microbiota in 
CD, but until now, this has not been studied in identical twins. 
 
In Papers II and III, the fecal and mucosal microbiota (5 biopsy locations, 
ranging from terminal ileum to rectum) of ten twin pairs were explored 
with different molecular approaches to identify microbial components of 
importance in CD. Six of these pairs were discordant, and four concordant 
for CD. In addition, fecal samples from eight healthy twin pairs (5 
monozygotic and 3 dizygotic) were included to study similarities in the 
microbiota within healthy pairs (Paper II). The main approach used to 
assess the microbial population structure was T-RFLP using both general 
and group specific primers (Papers II and III). In addition, the results were 
verified with quantitative PCR (Paper III) and in a subset of samples, with 
%G+C profiling (Paper II) and conventional cloning (Papers II and III). 
The new and promising technique, 454-FLX pyrosequencing, was also used 
to assess the fecal microbiota from all discordant and concordant twin pairs 
with CD and the mucosal microbiota from two biopsy locations, from the 
majority of the twins (ileum; samples from 16 individuals, and descending 
colon; samples from 14 individuals). In total, 136,848 16S rRNA gene   42
sequences were recovered and classified against the databases, (RDP II 
classifier), with a discrepancy at 95% identity (manuscript in preparation).  
5.2.1 Differences in the microbiota within twin pairs 
In Paper II, it was shown that healthy twins have high similarities in their 
fecal microbial profiles (Figure 5) and this finding is consistent with the 
published literature (Stewart et al., 2005; Van de Merwe et al., 1983; 
Zoetendal et al., 2001a). By contrast, comparison of the fecal microbiota of 
the discordant twin pairs revealed large differences between the healthy and 
the sick individuals within any given pair (Figure 5). In addition, the 
concordant CD twin pairs, did not have similar microbial profiles (Figure 5) 
and the observed differences were in the same range as for the discordant 
pairs. Furthermore, analysis of the mucosal microbiota in the biopsies 
supported the observations from feces and showed a large disagreement in 
the microbiota within discordant and concordant twin pairs. (Figure 5, 
Paper III). As previously reported (Lepage et al., 2005; Zoetendal et al., 
2002) there was a high consistency of the microbial profiles in biopsies 
collected at different locations within an individual, and in Paper III, we 
found that this was true regardless of the disease state (Figure 5).  
 
Figure 5. Similarity scores for pair wise comparisons of microbial community profiles derived 
from T-RFLP data (feces and biopsies). Reproducibility of the T-RFLP method (from 
duplicated fecal samples), is indicated by “replicates” and averages with standard deviations 
are represented in the upper box. Similarities of T-RFLP profiles derived from different 
locations in the terminal ileum and large bowel are indicated “biopsy location”. In addition, 
similarity scores were calculated for healthy, discordant and concordant twins. The data 
originates from pair wise comparisons of Manhattan distances. The boxes represent the mean 
and standard deviations for all comparisons made within a group. n; represents the number of 
pair wise comparisons performed. ICD; ileal Crohn’s disease, CCD; colonic Crohn’s disease.   43
5.2.2 Clustering according to the disease phenotype 
Multivariate data analysis revealed that there was a subset of the CD patients 
that grouped separately from the others. This clustering was correlated to the 
disease phenotype rather than the genetic relatedness. The CD patients with 
the ileal disease phenotype clustered together clearly separated from the 
healthy individuals, whereas the group with the disease located in the colon 
were not significantly different from the healthy individuals (Papers II and 
III). This result was consistent along the length of the large bowel as well as 
in feces. In addition, this result was consistent for the different analytical 
approaches used (Figure 6). Both T-RFLP and 454-FLX pyrosequencing 
differentiate the bacterial communities in patients with ICD. By contrast, 
the CCD patients cluster with the healthy individuals suggesting that the 
microbiota is impacted more in the ileal disease phenotype than in the 
colonic phenotype. Several other reports have only been able to demonstrate 
an imbalance in a subset of CD patients (Baumgart et al., 2007; Frank et al., 
2007). Due to the heterogeneity of this disease, the current findings lend 
support to the hypothesis that the composition of the gut microbiota may 
play a more important role in the ileal disease phenotype. There are a 
number of other findings that support this idea. Mutations in the 
NOD2/CARD15 region, encoding receptors for bacterial recognition, are 
correlated to the ileal disease phenotype (Ahmad et al., 2002). Furthermore, 
deficiency in the production of alpha defensins produced by Paneth cells in 
the ileum correlates with the ileal disease phenotype, and mainly with 
patients that have mutations in NOD2/CARD15 region (Wehkamp et al., 
2005). In addition, the ileal disease phenotype has been associated with 
higher levels of ileum associated E. coli with invasive properties (Baumgart et 
al., 2007; Darfeuille-Michaud et al., 1998).    44
 
 
Figure 6. Clustering of microbial profiles according to the species composition in fecal 
samples originated from discordant and concordant twins. Bray Curtis index was used as a 
distance matrix and the dendrogram was based on UPGMA clustering representing data from 
T-RFLP analysis and 454-FLX. The numbers represent the twin pairs and the letters (A or 
B) represent the individuals within a pair. Coloring of branches: red, ICD; blue, CCD; and 
green, healthy individuals. *Represent individuals that originally were classified as ileocolonic 
disease phenotype (Paper II), but were reclassified as predominantly having ICD or CCD 
(Paper III). 
5.2.3 Microbial diversity in Crohn’s disease  
The TRF diversity was higher among the healthy individuals compared to 
CD patients. In addition, among the discordant twin pairs, the healthy twin 
consistently had the higher diversity index (Papers II and III). Diversity 
measures based on T-RFLP data are however restricted to the dominant 
community members. The same diversity index was used to calculate the 
microbial diversity based on the 454-FLX data. This method allows a more 
in depth analysis of the microbial diversity. Interestingly, the results obtained 
with the T-RFLP data were in good agreement with the data obtained with 
454-FLX. From the 454-FLX data, it was shown that the diversity among 
the Firmicutes was reduced in the ICD patients but not in CCD patients 
compared to healthy individuals (Figure 7). A previous study showed that 
the fecal microbiota from six CD patients revealed a clear reduction in 
diversity within the Firmicutes phylum when a metagenomic library was 
compared between healthy individuals and CD patients (Manichanh et al., 
2006). Most prominent was a depletion of members of the Clostridium leptum   45
group (Clostridium cluster IV) (Manichanh et al., 2006)(Manichanh 2005). 
Strikingly, all of these patients had CD with ileal involvement.  
 
Figure 7. Relative abundances of sequences obtained using the 454-FLX approach that were 
classified to the genus level. Explanation of the abundance intervals is shown in a progressive 
blue scale with higher abundances correlating with darker colors. The abundance profile for 
each sample represents a column and the abundance for each genus as a row. Color scale to 
the left represents which phylum the genus belongs to: green, Actinobacteria; red, Bacteroidetes; 
light blue, Firmicutes; orange, Fusobacteria; Dark blue, Proteobacteria. To reduce space of the 
figure, genera that did not have any representatives with abundances over 0.5 % in any of the 
samples were removed. The samples were sorted according to their clustering with Bray 
Curtis index as a distance matrix and UPGMA as a dendrogram. Branch color represents: red, 
ICD; blue, CCD; and green, healthy individuals. *Represents individuals that originally were 
classified as ileocolonic disease phenotype (Paper II), but were reclassified as predominantly 
having ICD or CCD (Paper III). 
5.2.4 Targeting subgroups of the microbiota 
5.2.4.1 Bacteroides spp. 
There were some indications when the fecal T-RFLP data were analyzed, 
that there was a difference in abundance for some of the TRFs that 
putatively could be identified as Bacteroides species (Paper II). This genus is   46
one of the dominant members of the microbiota, (confirmed with the 454-
FLX data, manuscript in preparation), and some species are capable of 
inducing colitis in an animal model (Sartor, 2003). Therefore, the Bacteroides 
community was studied in more detail using primers that target the B. fragilis 
subgroup. Obtained TRF profiles showed very high similarities for some of 
the twin pairs but this similarity was not specifically correlated with the 
disease status (Paper II). However, in agreement with the results for the 
dominant microbiota, the disease phenotype discriminated the clustering of 
the  Bacteroides data was segregating according to disease phenotype. In 
particular, the TRF that correlated with B. uniformis (TRF 262, Figure 8) 
had a significantly lower abundance within the ICD patients (P =0.005). 
Instead, there was a trend towards increased abundances of the TRFs 
correlated with B. ovatus (TRF 264, P =0.08) and B. vulgatus (TRFs 83 and 
142, P = 0.12) in the subset with ICD compared with the healthy 
individuals and the CCD patients (Figure 8).  
 
Figure 8. Relative abundances (A) and diversities (B) of Bacteroides community members 
found within the fecal microbiota of discordant and concordant twins. Panel A, shows the 
relative abundances of sequences classified as Bacteroides spp. (454-FLX data) for each 
individual, grouped according to disease phenotype. Panel B, shows the relative abundances 
of the detected TRFs, representing members from the B. fragilis subgroup. Each bar 
represents the T-RFLP profile obtained from an individual. The colors representing the 
different TRFs, are shown in the bottom of the figure. *Represent individuals that originally 
were classified as ileocolonic disease phenotype (Paper II), but were reclassified as 
predominantly having ICD or CCD (Paper III).   47
The 454-FLX data showed that the abundance of the Bacteroides genus was 
not significantly higher in the ICD patients, compared with CCD patients 
or healthy individuals. Furthermore, Bacteroides abundances were higher in 
fecal samples than in biopsies for most of the individuals. Other studies have 
assessed the abundance and diversity of Bacteroides spp. in the gut, however 
with conflicting results (Frank et al., 2007; Gophna et al., 2006; Ott et al., 
2004; Scanlan et al., 2006; Swidsinski et al., 2002). A predominance of 
Bacteroides, and foremost B. vulgatus, was previously reported from CD 
patients (Gophna et al., 2006). In addition, higher levels of Bacteroides were 
found on the mucosa of CD patients compared to healthy individuals 
(Swidsinski et al., 2002). In contrast, Scanlan et al. (2006) failed to amplify 
Bacteroides in 39% for the CD patients and argued that this was not a 
methodological failure but depleted levels of this genus. In support of that 
finding, Takaishi et al. (2007) reported reduced abundances of B. uniformis as 
well as B. ovatus and B. vulgatus in CD patients. The inconsistent results 
found in abundance of Bacteroides can reflect differences in patient 
populations and methodologies, but it can also argue for CD disease as a 
group of related disorders rather than a distinct disease.      
5.2.4.2 E. coli 
Increasing interest has been directed towards E. coli and its prevalence in CD 
patients. Elevated levels of epithelium adherent and invasive strains of E. coli 
(AIEC) have been reported in the ileal mucosa (Darfeuille-Michaud et al., 
1998) an in particular in CD patients with the ileal disease phenotype 
(Baumgart et al., 2007). In Paper III the relative abundance of E. coli was 
investigated with qPCR. In agreement with the literature, the prevalence 
and abundance of E. coli was correlated with ICD and was rarely present in 
the healthy individuals. However, in contrast to previous publications, the 
results in Paper III showed that E. coli was not restricted to the ileal mucosa 
(Figure 9). The higher incidence and relative abundance of E. coli was 
constant along the large bowel, which is consistent with data from an older 
study (Keighley et al., 1978).    48
 
Figure 9. Relative abundance of E. coli along the digestive tract of the twins, grouped 
according to their disease state. Each bar shows the average abundance of E. coli for a specific 
biopsy location and error bars represent standard error of the mean. The sample location is 
abbreviated below each bar, I; ileum, A; ascending colon, T; transversal colon, D; descending 
colon, R; rectum. Abbreviations for disease phenotypes, ICD; ileal Crohn’s disease, CCD; 
colonic Crohn’s disease. 
The increased levels of E. coli, observed in Paper III as well as in other 
studies could be of clinical significance because this bacterium has a number 
of features that may be of importance in CD. For example, animal models 
have shown that E. coli increases the permeability of the epithelium, 
although without physical damage (Garcia-Lafuente et al., 2001). An altered 
intestinal permeability has been observed in CD patients as well as among 
their healthy relatives (Hilsden et al., 1996).  
 
The ileal disease phenotype is associated with a deficiency in release of 
antimicrobial peptides, such as alpha-defensins (Wehkamp et al., 2005). This 
could explain the higher prevalence of E. coli in tissues from ICD patients. 
However, alpha defensins are produced by paneth cells restricted to the 
ileum, and are not produced in colonic tissues. A deficiency in these 
antimicrobial peptides would presumably increase a localized response with 
increase of bacteria associated to ileal tissues. The consistent increase of E. 
coli along the digestive tract, in ICD patients suggest that other mechanisms 
are involved.   
5.2.4.3 Faecalibacterium 
The analysis of the TRF data in Papers II and III identified one TRF that 
was discriminated according to the disease phenotype. TRF 223 was present 
in all biopsies and fecal samples from the healthy group and the CCD 
patients, with average abundances of 11% and 15% respectively. However, 
in patients with ICD, this TRF was absent or present in scarce abundances   49
(Figure 10). Cloning and sequencing revealed that this TRF correlated with 
sequences similar to Faecalibacterium prausnitzii (Figure 10). The depleted 
abundances of F. prausnitzii were verified with the 454-FLX data and with 
qPCR data (Figure 10). By comparing the twins, is was shown that both the 
concordant pairs with ICD and the diseased twin in the pairs with ICD had 
no or moderate abundance of Faecalibacterium whereas the healthy individuals 
in the ICD pairs as well as all pairs with CCD had this bacterium in 
substantial levels.  
 
 
Figure 10. Abundance of Faecalibacterium in healthy individuals, ICD and CCD patients. The 
upper panel shows the relative abundance of TRF 223, the mid panel, relative abundance of 
Faecalibacterium from the 454 data, and the lower panel shows the abundance of F. prausnitzii 
assessed with qPCR. Sample location is indicated below each panel, with the abbreviations, I; 
Ileum, A; ascending colon, T; transversal colon, D; descending colon, R; rectum, and F; 
feces.      50
 
Studies of the intestinal microbiota have revealed large inter-individual 
differences. Despite great differences between individuals the prevalence of 
F. prausnitzii seems to be consistent in almost all individuals. This has been 
shown in several studies (Lay et al., 2005; Mueller et al., 2006; Suau et al., 
2001) and in Paper I, where TRF 223, representative of F. prausnitzii was 
present in 89/90 children. However, several studies have reported a 
depletion of members of the C. leptum group (which includes F. prausnitzii 
as the dominant member) in CD patients (Baumgart et al., 2007; Frank et al., 
2007; Manichanh et al., 2006; Martinez-Medina et al., 2006; Scanlan et al., 
2006; Swidsinski et al., 2008; Vasquez et al., 2007). In the literature, this 
depletion is usually restricted to a subset of CD patients. The data from 
Papers II, III and the 454-FLX data (manuscript in preparation), suggest 
that this depletion is correlated to the disease phenotype. Interestingly, a 
recent publication showed results that are in agreement with our findings, 
with scarce abundances or absence of Faecalibacterium in patients with the 
ileal disease phenotype but similar abundances in healthy individuals and 
those with the colonic disease phenotype (Baumgart et al., 2007). These 
authors suggest that localized dysbiosis of the mucosa associated bacteria is 
casually related to ileal inflammation. However, in that study, only the ileal 
microbiota was analyzed. The results in Papers II, III and the 454-FLX 
data, do not support the hypothesis that dysbiosis is localized to a specific 
region, although higher numbers were found in the biopsies at all locations 
than in feces. The depletion of F. prausnitzii, was consistent along the 
digestive tract independent of the analytical approach used. In addition, 
previous investigations comparing inflamed and non-inflamed tissues have 
failed to detect differences suggesting that dysbiosis is consistent along the 
length of the colon and not localized in CD patients.  
 
Interestingly, it has been shown that depleted levels of F. prausnitzii can be 
restored with high doses of immune suppressive drugs, suggesting that the 
absence of F. prausnitzii is due to an activated immune response, which 
specifically eradicates selective groups of bacteria (Swidsinski et al., 2008). 
Removal of medication resulted in a gradual reduction of F. prausnitzii until 
it was completely absent (Swidsinski et al., 2008). F. prausnitzii is known as 
one of the major producers of butyrate in the bowel. Production of short 
chain fatty acids, and in particular butyrate is thought to be important for 
maintaining health (Pryde et al., 2002). Interestingly, reduced levels of 
butyrate have been reported from CD patients previously (Marchesi et al., 
2007; Takaishi et al., 2007). Besides its properties as fuel for the epithelium, 
butyrate is thought suppress expression of proinflammatory cytokines   51
(Segain et al., 2000) and may be of critical importance for maintaining 
health.  
5.3 The microbiota in patients with gastric cancer 
Persistent infection of H. pylori is associated with an increased risk for 
developing atrophic gastritis and gastric cancer. It is generally accepted that 
H. pylori causes gastritis but its role in the progression into gastric cancer is 
not evident. In the published literature, it has been suggested that the 
increased pH of the atrophic stomach allows survival of more genotoxic 
bacteria that may be of toxicological significance (Blaser & Atherton, 2004; 
Heavey & Rowland, 2004). However, few studies have characterized the 
non-Helicobacter bacterial flora in patients with gastric cancer and the studies 
performed to date have mainly relied on cultivation techniques, which has 
been shown to discriminate against a large fraction of the gut microbiota 
residing within the gastrointestinal tract (Bik et al., 2006; Eckburg et al., 
2005).  
 
In Paper IV, the stomach microbiota of ten patients with gastric cancer was 
characterized and compared with five dyspeptic controls that visited the 
hospital for abdominal pain, but without any signs of morphological changes 
on the gastric mucosa. The bacterial community structure was assessed with 
T-RFLP and by cloning and sequencing of 16S rRNA genes that were 
PCR amplified from biopsies collected from a subset of the cancer patients. 
The cancer patients as well as the controls had a diverse assemblage of TRFs 
and each individual had a unique bacterial community profile. There was no 
significant difference in the TRF profiles between cancer patients and the 
control group (P=0.12). It was not possible to conclude if the stomach of 
the gastric cancer patients were subject for bacterial overgrowth since the 
bacterial load was not quantified and furthermore, no data of the gastric pH 
was collected in any of the individuals. Despite these shortcomings some 
interesting and novel information was obtained about the composition of 
the bacterial communities in individuals with stomach cancer. 
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Figure 11. Phylogenetic distribution of clones recovered from gastric cancer patients. 
Terminal restriction fragment abundances resulting from the T-RFLP analyses of the gastric 
cancer patients that were correlated to 16S rRNA gene sequences from the same individuals 
are represented by the bar graph in the center and compared with the phylogenetic 
distribution of 16S rRNA gene sequences isolated from the stomach of healthy subjects to 
the right (Dethlefsen et al., 2007). Colors represent different phyla: light blue, Firmicutes; 
orange, Fusobacteria; Dark blue, Proteobacteria; green, Actinobacteria; red, Bacteroidetes; and grey, 
TRFs that could not be correlated to 16S rRNA gene sequences.  
To be able to correlate the data from the TRF analysis, cloning and 
sequencing of 16S rRNA genes was performed in a subset of the gastric 
cancer patients.  In total the gastric cancer microbiota revealed 102 
phylotypes, predominantly belonging to Firmicutes (Figure 11). Five phyla 
were represented among the sequenced clones (Firmicutes,  Bacteroidetes, 
Proteobacteria, Actinobacteria and Fusobacteria) and many of these are normally 
found in the oral cavity (Aas et al., 2005). The proportions of the phyla 
found in the clone libraries agree with a previous study of the gastric 
microbiota of healthy individuals that was also obtained using the same 
approach (Figure 11; Dethlefsen et al., 2007). H. pylori was rarely found 
among the sequenced clones and was correlated to a TRF with low relative 
abundance. A scarce presence of H. pylori in stomachs with an altered gastric 
physiology has been observed previously (Blaser & Atherton, 2004). The 
non-Helicobacter microbiota may play an as yet undiscovered role for 
progression into gastric cancer. Paper IV at least presents the first step 
towards understanding the microbial community composition in patients   53
with gastric cancer. Further studies are required to establish whether any of 
the bacterial populations detected play a role in gastric cancer development 
or progression.  
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6 Conclusions 
 
The microbial profile within an individual is unique for that individual. 
However, in healthy identical twins, genetic factors or a shared microbial 
colonization history from infancy and early childhood, partly diffuse this 
individuality. This was confirmed by a very similar composition and 
diversity in the microbiota of identical twins. However, in twins discordant 
for CD, these similarities were no longer apparent suggesting that disease is 
one factor that can cause an imbalance in the composition of the commensal 
gut microbiota.  
 
Factors associated with the anthroposophic lifestyle were shown to correlate 
with an increased microbial diversity, which is thought to be generally 
beneficial for resilience against disturbances. However, presence of keystone 
members of the microbiota may compensate for a high microbial diversity, 
supported by the finding that farm children had a low microbial diversity, 
although, this lifestyle is also associated with a low risk in developing 
allergies and asthma.  
 
The hypothesis that keystone members are important for health is supported 
by our finding that depleted prevalence of potential key-members of the gut 
microbiota was correlated to the ileal disease phenotype in twins with CD. 
Specific disturbances in the microbiota of patients with ICD were correlated 
to a lower prevalence of Firmicutes, and most striking was the absence or 
scarce presence of F. prausnitzii along the length of the large bowel as well as 
in fecal samples from the ICD patients. Furthermore, the prevalence of E. 
coli was associated with ICD and was not, as previously reported, restricted 
to ileal tissues, but consistent to all sampling locations in the colonic mucosa.  
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Characterization of the microbial composition in the stomach from gastric 
cancer patients revealed a higher bacterial diversity than previously estimated 
using cultivation-based approaches. Bacterial populations from five different 
phyla were present. However, the diversity and community structure of the 
individuals with gastric cancer were not significantly different from those 
found in dyspeptic controls.  
 
The different methods used in this thesis have shown a high agreement that 
strengthens the validity of the results. For example, T-RFLP has a limitation 
in that it can only detect the dominant groups in complex microbial 
communities. By contrast, the 454-FLX approach enables deeper 
exploration of microbial communities due to the large number of sequences 
that can be generated. Therefore, one might expect a different species 
distribution to be obtained when comparing these two approaches. 
However, our results showed very high agreement between these two 
methods. Since T-RFLP is currently more rapid and inexpensive than 454- 
FLX sequencing, our results encourage the initial screening of large numbers 
of samples using the T-RFLP approach prior to selection of those for deeper 
assessment using 454-FLX.  
6.1 Future perspectives 
The key question of importance for inflammatory diseases of the gut remains 
unanswered. Is the inflammation itself causing a shift in the composition of 
the gut microbiota or is it the shift in the microbiota that causes 
inflammation? To be able to answer that question the first critical issue is to 
understand the relative contributions of the host and environmental factors 
to the dynamics of the microbiota. The current improvement in 
technologies, such as 454-FLX pyrosequencing, enables a more in depth 
analysis of the structural composition of the microbial community than was 
previously possible. Future advances in this technology are in the pipeline 
with predicted longer length reads. In addition, new sequencing approaches 
are being developed that might lower the sequencing costs and make this 
approach more feasible for screening large numbers of samples. This will 
provide important insights about microbial diversity and dynamics in large 
sets of individuals. In parallel, the functional repertoire of genes represented 
in the human microbiome and the expression of these genes as well as the 
metabolic products of active microbial populations in the gut (in a healthy 
compared to a diseased state) should be explored. This information would 
be useful to correlate structural shifts in the microbiota to an impaired 
metabolic function and will provide important insights into the beneficial or 
detrimental roles of specific microorganisms as an initiator/maintainer, or   56
guardian against intestinal diseases. These studies require good model systems 
to detect significant differences in human populations, and one excellent 
example is to continue to study identical twins, as in Papers II and III. 
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